Fidelity Investments’s Dare Bioscience DARE Stock Holding History

Fidelity Investments’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-42	Closed	-$169	–	5535
2024 Q2	$169	Sell	42 -48	-53%	-$233	﹤0.01%	4935
2024 Q1	$527	Buy	+90	New	+$441	﹤0.01%	4841
2023 Q3	–	Sell	-21	Closed	-$228	–	5316
2023 Q2	$228	Buy	+21	New	+$249	﹤0.01%	4886
2016 Q3	–	Sell	-15,327	Closed	-$3.9M	–	2661
2016 Q2	$3.9M	Sell	15,327 -13,123	-46%	-$4.2M	﹤0.01%	2239
2016 Q1	$9.25M	Sell	28,450 -4,303	-13%	-$1.21M	﹤0.01%	1994
2015 Q4	$11M	Hold	32,753	–	–	﹤0.01%	1957
2015 Q3	$14.4M	Hold	32,753	–	–	﹤0.01%	1793
2015 Q2	$18.1M	Buy	32,753 +13,075	+66%	+$8.98M	﹤0.01%	1766
2015 Q1	$21.3M	Sell	19,678 -584	-3%	-$565K	﹤0.01%	1708
2014 Q4	$15.1M	Hold	20,262	–	–	﹤0.01%	1853
2014 Q3	$10.3M	Hold	20,262	–	–	﹤0.01%	2006
2014 Q2	$14.1M	Buy	+20,262	New	+$15.6M	﹤0.01%	1944

Other funds holding DARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FFS

Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments's DARE Position: Q3 2024 in Review

Fidelity Investments sold out of Dare Bioscience (DARE) in Q3 2024, closing a stake of 42 shares — an estimated $169 sold.

Fidelity Investments first reported a position in DARE in Q2 2014 and held it in 12 quarters. The position peaked at $21.3M in Q1 2015. 22 funds tracked by Wall St. Rank hold DARE as of Q3 2024.

Fidelity Investments reported no remaining Dare Bioscience position as of Q3 2024 after selling out during the quarter.
Fidelity Investments sold 42 Dare Bioscience shares in Q3 2024, an estimated $169.
Fidelity Investments first reported a position in Dare Bioscience in Q2 2014 and held it in 12 quarters.
Fidelity Investments's Dare Bioscience position peaked at $21.3M in Q1 2015.
22 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2024.

Based on Fidelity Investments's 13F filing for Q3 2024, filed 13 Nov 2024.